Skip to main content
Premium Trial:

Request an Annual Quote

Robert Schwartz, Rowan Chapman, Arkesh Mehta


The Associated Press reported last week that bioinformatics pioneer Robert Schwartz was found dead in his Virginia home on December 12, the victim of an apparent slaying.

Schwartz was executive director for R&D and university relations at Virginia''s Center for Innovative Technology in Herndon. He had been with the center for 14 years. He was previously leader of an industrial consortium coordinated out of Georgetown University that created the first national online database of DNA sequence information.

At press time, no further information was available about Schwartz’s death.


VC firm Mohr Davidow Ventures has named Rowan Chapman — formerly director of business development at Kirkland, Wash.-based Rosetta Inpharmatics — as an entrepreneur-in-residence. In this position, Chapman will investigate new investments for Mohr Davidow, focusing on information technology companies working on life sciences applications.


Arkesh Mehta has left his position as chief information officer of the Biotechnology Industry Organization to launch his own bioinformatics consulting firm, Interoperable Informatics. Mehta said the company would offer biopharmaceutical organizations customized solutions for knowledge management and data integration.


Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.